Skip to main content

Table 3 Correlation of hypermethylation with clinicopathological variables (associations approaching significance, p < 0.05 in bold)

From: BRCA2 carriers with male breast cancer show elevated tumour methylation

 

GSTP1

RASSF1A

MAL

RUNX3

RARβ

APC

FOXC1

AMI (median)

Hypermethylation

+

-

+

-

+

-

+

-

+

-

+

-

+

-

>

<

Age (years)

    

59.1

65.7

  

67.2

60.9

69.1

60.4

    

p-value

     

0.04

   

0.07

 

0.01

    

Tumour size (mm)

        

22.3

16.5

21.4

17.1

  

20.8

15.8

p-value

         

0.01

 

0.08

   

0.02

IC-NST Histology

      

94%

69%

        

p-value

       

0.046

        

Grade 3

51%

18%

              

p-value

 

0.09

              

Paget’s Disease

        

31%

8%

      

p-value

         

0.04

      

DCIS present

  

33%

6%

            

p-value

   

0.02

            

Lymphovascular invasion

49%

18%

        

20%

51%

53%

40%

  

p-value

 

0.09

         

0.07

 

0.09

  

Perineural invasion

        

63%

36%

      

p-value

         

0.07

      

Node positive

  

52%

24%

    

62%

34%

      

p-value

   

0.08

     

0.07

      

HER2 positive

              

13%

0

p-value

               

0.11